New-Year-Picks-2025
New-Year-Picks-2025
New-Year-Picks-2025
Risks
• Automotive and High Engineering verticals continue to face headwinds for the Company. In the heavy
engineering space (which contributes 14% to topline), Caterpillar is the major client. Billing rates are not
impressive from this client and Co is currently negotiating with the client. Here again, revenues will be
flattish but Co expects significant improvement in margins going fwd.
• Automotive sector continues to lag due to loss of revenues from its OEM with Volkswagen. It expects this
vertical to follow industry level growth.
Figures in Rs Cr
Year Revenue Growth EBITDA Margin PAT Margin EPS PE EV/EBITDA ROCE
FY23 821.6 34.6% 141.7 14.0% -4.76 -0.6% -1.2 -89.9 13.2 16.6%
FY24 955.1 16.0% 133.2 10.4% 33.00 4.0% 8.0 56.2 15.2 18.5%
FY25E 1098.4 12.0% 164.8 11.4% 74.00 7.0% 17.7 34.1 17.5 22.2%
FY26E 1296.1 15.0% 207.4 12.5% 99.00 8.0% 23.7 24.9 13.6 24.5%
Birla Corporation
CMP: Rs. 1,243 | TP: Rs. 1,497| Upside: 20%
Birla Corporation, a MP Birla group company, is engaged in the business of manufacturing of cement & also has
presence in the jute business. Currently, cement capacity stands at 20 MTPA with 11 plants across Madhya Pradesh,
Uttar Pradesh, Rajasthan, Maharashtra & West Bengal. Cement business contributes 95% to total revenue, while jute
business contributes 5%
In the recent quarter, Birla Corporation faced significant challenges due to adverse external market conditions that
impacted both demand and pricing within the cement industry. The company's realization per ton for Q2 of FY2025
was ₹4,918, reflecting a 10% decline compared to the same quarter last year and a 2% decrease from the previous
quarter. Similarly, the EBITDA per ton also saw a sharp decline, dropping to ₹446, which represents a 35% decrease
from Q2 FY2024 and a 24% drop from the preceding quarter.
Company sustained its premium product sales were up in Q2 of FY2025, sales of premium products constituted 62%
of the sales mix, up from 54% in Q2 FY2024. Additionally, power and fuel costs saw a significant dip on half yearly
basis, they came at 1014 per/ton v/s 1168 per/ton in h1 of 2024 . To further improve energy efficiency the company
continues to emphasize on renewable energy, which made up 24.2% of total power consumption in FY2023-24.
The company plans to increase its cement production capacity from 20 MTPA to 25 MTPA by FY2027. This expansion
includes a 1.4 MTPA increase at the Kundanganj plant, expected to be commissioned in Q1 FY2026, and a similar
expansion at the Prayagraj facility, with a future commissioning date. These initiatives are projected to positively
impact the company's topline performance, enabling it to better meet rising demand in the cement market and
enhance its competitive positioning.
Birla Corporation
CMP: Rs. 1,243 | TP: Rs. 1,497| Upside: 20%
Valuation
• The company experienced muted growth in its financial performance during the first half of FY2025, is
anticipated to witness revival in the second half of the fiscal year. This expected improvement is driven by
increased demand, government spending, and the ramp-up of existing capacities. Furthermore, the EBITDA per
ton, which currently stands at ₹423.92, is projected to rise due to enhanced realization and a continued focus on
cost reduction. Additionally, the growing share of premium products in the company's sales mix is expected to
positively impact future EBITDA per ton, contributing to improved profitability.
• To optimize costs, Birla Corporation Limited has initiated several strategic projects, including Project Shikhar and
Project Unnati. These initiatives have successfully resulted in gross savings of approximately ₹66cr and ₹100cr,
respectively, in FY24. By focusing on enhancing operational efficiencies and streamlining processes, the company
aims to further improve its cost structure and overall profitability.
• Stock is currently trading at 8.7x to FY26 EV/EBITDA. We assign 10x to FY26E EBITDA to arrive at a target of
Rs. 1,497/share with an upside of 20% over the CMP.
Figures in Rs Cr
Year Volume Revenue Growth EBITDA Margin PAT Growth EPS EV/EBITDA
Year Revenues Growth EBITDA Margin PAT Growth EPS PE EV/EBITDA ROE
FY23 11315 21% 974 6.4% 182 156% 46.02 67.9 14.9 5%
FY24 11944 6% 1652 13.8% 701 285% 173.0 18.1 8.8 17%
FY25E 13130 10% 1548 11.8% 583 -17% 144.3 21.7 9.4 13%
FY26E 14642 12% 1863 12.7% 770 32% 187.5 16.7 7.8 16%
FY27E 16132 10% 2121 13.1% 916 19% 214.4 14.6 6.8 16%
Elecon Engineering Co.
CMP: Rs. 642 | TP: Rs. 892| Upside: 39%
Elecon is a manufacturer of industrial gears (~80% mix) & material handling equipment (MHE) (~20% mix). It
is a proxy on industrial capex across cement, steel, mining, power, oil & gas and other sectors.
Elecon is the leader in industrial gears with a market share of 35% in India.
Elecon witnessed a temporary slowdown in its gear business during H1FY25 owing to elections which
delayed ordering activity during Q1FY25 (inflows down 11% YoY). Order inflows have recovered in Q2FY25
(+15% YoY) and shall gain further momentum and translate to strong execution from Q3FY25.
After a decade of juggling issues related to legacy EPC projects, the MHE segment has completely turned
around from losses in FY22 to reaching segmental margins of ~26% in H1FY25. Unlike before, it no longer
participates in EPC projects and all new orders are for products or after-market sales. Order book in MHE has
increased by 176% YoY to Rs. 339 Cr in Q2FY25 which provides strong growth visibility.
We believe Elecon witnessed an election led temporary slowdown during H1FY25 and shall stage a strong
comeback from Q3FY25 onwards. We expect a CAGR of 18%/22% in revenue/profits, over FY25–27E along with
stable ROCE of 26%. We assign a TP of Rs. 892, valuing the company at 25x 2027E EPS.
Figures in Rs Cr
Year Revenues Growth EBITDA Margin PAT Growth EPS PE EV/EBITDA ROCE
FY24 1937 27% 474 24.5% 356 50% 15.8 40.5 29.2 28%
FY25E 2201 14% 510 23.2% 385 8% 17.2 37.4 27.2 25%
FY26E 2597 18% 615 23.7% 474 23% 21.1 30.4 22.6 26%
FY27E 3045 17% 729 23.9% 572 21% 25.5 25.2 19.0 26%
Privi Speciality Chemicals
CMP: Rs. 1,688 | TP: Rs. 2,126| Upside: 26%
Privi Speciality Chemicals Ltd is primarily engaged in the manufacturing, supply and exports of aroma and fragrance
chemicals used in soaps, detergents, shampoos, and other fine fragrances. It started its manufacturing operations in 1992
from Unit -1 at Mahad.
Strong growth expected backed by expansion in existing capacity as well as new projects
• Though the company faced many challenges about margin contraction and decline in product prices by 30-40% over the
last 3-4 years, it has seen improved margins over the last six quarters backed by solid growth in core products, change in
product mix and contribution from all new products like Galaxmusk & its variant, Camphor & allied product and Prionyl.
• Privi is also focusing on enhancing its existing capacity in order to ensure the supply of its products as per the rising
market demand (at present running at ~80-85% utilization). New products such as Galaxmusk and Prionyl are expected to
run at peak capacity in the coming year and the management expects better volumes in the upcoming quarters.
• Privi has taken an approval for to raise up to ~Rs. 1000 cr through QIP for the following – i. Menthol & other high ended
Speciality products (Capex Rs. 550-600 crs) to be commissioned in 18 months post fund raises, ii. Capacity expansion of all
core products like DHMOL, Amber Fluer, Pine Oil, Prionyl (Capex Rs.250-300 crores to be commissioned in 12 months' time),
iii. Investment in Privi Fine Science for Green Field Project.
Focus on sustainability to drive Privi’s long term growth based on its vision
• Sustainability remains core at Privi’s business operations. While it is committed to achieve UN sustainable development
Goals, it has received Ecovadis Gold in Mar’24 (amongst world’s top 5% companies). It is a zero liquid discharge company.
Privi’s new green project: Menthol, which is developed based on its in-house technology to produce menthol through
renewable feedstock which is named as ‘Levomenthol’. This product is sustainable in nature and expects to support future
government mandate on the use of renewables in various FMCG products.
Privi Speciality Chemicals
CMP: Rs. 1,688 | TP: Rs. 2,126| Upside: 26%
Further, JV with Givaudan, a global leader in fragrance and Beauty emphasizes Privi’s competent capabilities in the global
market. This strategic initiative has unfolded various opportunities for future growth.
Valuation
• Privi’s strategic alliances with big MNC players such as Givaudan, BASF, etc. backed by its strong R&D with ability to
deliver reliable and sustainable products has established its prominent position in the market. It ensures to sustain its
leading position in its key products such as Dihydromyrcenol, Amber Fleur, and the Pine Oil. Galaxmusk and its variants
have performed well in the initial year of its operations.
• It can achieve Rs. 2200-2500 cr of revenue at its existing capacity of 48000 MTPA considering current prevailing prices.
The management expects prices to improve for FY26. The company is in the process of finalizing contracts with all its top
customers for the CY2025 before Dec’24.
• Privi’s topline is expected to grow at ~22% CAGR between FY24-26E with 58% growth in bottom-line. As a result, return
ratios are expected to improve from ~11% in FY24 to ~18% in FY26E. The management has guided a strong fundamental
growth, where topline is expected at ~Rs. 5000 cr over the next 4-5 years with greater than ~20% EBITDA margin. We
assign PE Valuation of 35x to FY26E EPS to arrive at a target of Rs. 2,126/share with an upside of 26% over the CMP.
Figures in Rs Cr
Year Revenue Growth EBITDA Margin PAT Growth EPS PE EV/EBITDA ROE
FY23 1,608 14.5% 186 11.6% 20 -77.9% 5.21 211.2x 28.7x 2.4%
FY24 1,752 8.9% 325 18.6% 95 366.6% 24.30 52.6x 18.3x 10.7%
FY25E 2,100 19.9% 420 20.0% 163 72.1% 41.81 40.7x 18.2x 15.6%
FY26E 2,600 23.8% 546 21.0% 237 45.3% 60.75 28.0x 14.0x 18.6%
Samhi Hotels
CMP: Rs. 196 | TP: Rs. 269| Upside: 38%
SAMHI Hotels Limited (SHL) is a branded hotel ownership and asset management platform. It has a portfolio of 5108 keys across
32 operating hotels in 13 cities. SHL operates under well-recognized hotel brands such as Courtyard by Marriott, Hyatt Place,
Sheraton, Hyatt Regency, Renaissance, Fairfield by Marriott, Holiday Inn Express etc. Company operates in Upper upscale,
Upscale, Upper middle, and Middle scale categories hotel. SHL mainly focuses on business Hotels.
SHL is on track for strong growth through new assets in key markets, expansion of existing inventory and renovation/
rebranding of some of its existing hotels.
Recently, the Co has renovated and reopened 133 roomed Caspia Pro in Greater Noida as Holiday Inn Express. Co is likely to
benefit from strong demand in Greater Noida.
Co has also acquired 100% stake in Inmar Tourism and Hotels in Oct’24 adding 142 rooms immediately to its existing portfolio.
Co will be renovating and upgrading these rooms which later will have potential of higher RevPAR and better margins. Further, it
will be constructing 200-220 rooms here funded through internal accruals.
SHL has signed a long-term variable lease agreement in Hitec City, Hyderabad to develop an Upper Upscale hotel with 170 -
175 rooms.
On similar lines, 167- room new hotel in Calcutta and Bangalore (under the Holiday Inn Express brand) have also been
completed and are currently under pre-opening stage and is expected to be operational in FY25.
SHL’s strategy of acquisition led growth and transforming under-performing hotels has paved well for it. It continues to focus on
large office and aviation markets allowing it a predictable, strong and sustainable growth. We are positive on company’s long
term performance backed by strong demand environment. We assign EV/EBITDA multiple of 15x to FY26 EBITDA to arrive at a
target of Rs. 269/share with an upside of 38%.
Figures in Rs Cr
Year Revenue Growth EBITDA Margin PAT Margin EPS EV/SALES EV/EBITDA ROE
FY23 7586.0 35.7% 1020.5 13.5% 321.3 4.2% 0.7 6.3 46.8 6.2%
FY24 8911.9 17.5% 1248.6 14.0% 461.9 5.2% 1.0 5.3 38.2 8.2%
FY25E 10528.9 18.1% 1488.5 14.1% 565.7 5.4% 1.3 4.5 31.9 9.5%
FY26E 12389.8 17.7% 1791.9 14.5% 715.3 5.8% 1.6 3.8 26.3 11.1%
Performance-2024 Picks
Jehan Bhadha Banks & NBFC, Auto, Capital Goods jehankersi.bhadha@nirmalbang.com 6273 8174
Devendra Pawar Banks & NBFC, Auto, Capital Goods devendra.pawar@nirmalbang.com 6273 8149
Research Reports that are published by Nirmal Bang Securities Private Limited (hereinafter referred to as “NBSPL”) are for
private circulation only. NBSPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having
Registration no. INH000001766. NBSPL is also a registered Stock Broker with National Stock Exchange of India Limited, BSE
Limited, Metropolitan Stock Exchange of India Limited, Multi Commodity Exchange of India Limited and , National Commodity
and Derivative Exchange Limited in Capital Market , Equity and Commodities derivatives segments and Currency Derivatives
Segment .
NBSPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times,
have different or contrary views on stocks and markets.
NBSPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in
securities Market since last 20 years. NBSPL, its associates or analyst or his relatives do not hold any financial interest (Except
Investment) in the subject company. NBSPL or its associates or Analyst do not have any conflict or material conflict of interest
at the time of publication of the research report with the subject company. NBSPL or its associates or Analyst or his relatives
may or may not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately
preceding the date of publication of this research report.
NBSPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of
the company covered by Analyst during the past twelve months. NBSPL or its associates have not received any compensation or
other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not
served as an officer, director or employee of Subject Company. NBSPL / analyst has not been engaged in market making
activity of the subject company.
Analyst Certification: The research analysts and authors of these reports, hereby certify that the views expressed in this
research report accurately reflects my/our personal views about the subject securities, issuers, products, sectors or industries.
It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the
inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of
this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any
recommendations.
DISCLAIMER
The Research Report is for the personal information of the authorized recipient and does not construe to be any investment,
legal or taxation advice. NBSPL is not soliciting any action based upon it. Nothing in the research report shall be construed as
a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In
preparing the research report, we did not take into account the investment objectives, financial situation and particular
needs of the reader.
The research report has been prepared for the general use of the clients of NBSPL and must not be copied, either in whole or
in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use
or disclose the information in the research report in any way. Though disseminated to all the customers simultaneously, not
all customers may receive the research report at the same time. NBSPL will not treat recipients as customers by virtue of
their receiving the research report. The research report is not directed or intended for distribution to or use by any person or
entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be
contrary to law, regulation or which would subject NBSPL & its group companies to registration or licensing requirements
within such jurisdictions.
The report is based on the information obtained from sources believed to be reliable, but we do not make any representation
or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to
correct or update the information or opinions in it. NBSPL or any of its affiliates or employees shall not be in any way
responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in
the research report. NBSPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty
of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of
merchantability, fitness for a particular purpose, and non-infringement. The recipients of the research report should rely on
their own investigations.
This information is subject to change without any prior notice. NBSPL reserves its absolute discretion and right to make or
refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBSPL is committed to
providing independent and transparent recommendations to its clients, and would be happy to provide information in
response to specific client queries.
DISCLAIMER
Before making an investment decision on the basis of research report, the reader needs to consider, with or without the
assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and
financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an
individual security may even become valueless. International investors are reminded of the additional risks inherent in
international investments, such as currency fluctuations and international stock market or economic conditions, which may
adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the
company nor the director or the employees of NBSPL accept any liability whatsoever for any direct, indirect, consequential or
other loss arising from any use of the research report and/or further communication in relation to the research report. Here it
may be noted that neither NBSPL, nor its directors, employees, agents or representatives shall be liable for any damages
whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in
connection with the use of the information contained in the research report.
Registration granted by SEBI and certification from NISM in no way guarantee performance of NBSPL or provide any assurance
of returns to investors.